Hepatocellular Cancer Recruiting Phase 2 Trials for Sorafenib (DB00398)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03037437Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular CancerTreatment